Stock CSSI COSTAS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Costas, Inc.

Equities

CSSI

US22160A2069

Market Closed - OTC Markets
Other stock markets
 11:14:24 2024-04-12 am EDT 		5-day change 1st Jan Change
0.034 USD +39.92% Intraday chart for Costas, Inc. 0.00% +18.47%
2023 Costas, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2023 Costas, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Costas, Inc. Announces Filing of Annual Report for FYE 2023 and Rescinding of Cease Trade Order in Canada
PR
Standard Dental Labs Inc. Addresses Retirement Crisis Among Baby Boomer Dental Lab Owners
PR
Costas, Inc. Embraces Unprecedented Growth in Florida's Thriving Dental Industry
PR
Costas, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Costas, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Costas, Inc. Auditor Raises 'Going Concern' Doubt
CI
Costas, Inc. Auditor Raises 'Going Concern' Doubt
CI
Costas, Inc. acquired Assets from Prime Dental Lab, LLC for $0.7 million.
CI
Costas : Completes Acquisition of Florida Based Dental Lab, Prime Dental Lab, LLC
PU
Costas, Inc. executed a definitive agreement to acquire Assets from Prime Dental Lab, LLC for $0.7 million.
CI
Costas, Inc. (OTCPK : CSSI) completed the acquisition of Standard Dental Labs Inc.
CI
Costas, Inc. (OTCPK : CSSI) made an offer to Standard Dental Labs Inc.
CI
Atlas Nanotech Targets the World’s Largest Consumer Health Products Companies to License the FirstEver Nanotechnology Vitamin A (Retinol) Based Crystalline Eye Drop
GL
Atlas Nanotech Announces the Successful Development of the First Ever ‘Over The Counter’ Vitamin ‘A’ (Retinol) Eye-Drops
GL
Atlas Nanotech Opens First Revenue Stream
GL
Atlas Nanotech of Guadalajara to begin alliance with European Nano Medical S.R.O.
GL
Costas, Inc. to Begin Alliance with European Nano Medical S.R.O
CI
Costas, Inc. Appoints New Management and Board Members
CI
Costas, Inc. entered into a share exchange agreement to acquire Atlas Nanotech for MXN 48.9 million.
CI
Costas, Inc. Anticipates Recently Signed Farm Bill to Have Significant Impact on CSSI Initiatives in Hemp, Cannabis Industry
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CSSI Stock
  4. News Costas, Inc.